Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas

Oncogene

Volumn 14, Issue 24, 1997, Pages 2979-2984

  Edelson, M I ^a   Scherer, S W ^c   Tsui, L C ^c   Welch, W R ^a   Bell, D A ^b   Berkowitz, R S ^a   Mok, S C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Borderline; Cancer; Chromosome 7; LOH; Ovary

Indexed keywords

ARTICLE; CANCER INVASION; CHROMOSOME 7Q; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENE LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; DNA, NEOPLASM; DNA, SATELLITE; EPITHELIUM; FEMALE; GENE DELETION; HETEROZYGOTE; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0030792170     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201271     Document Type: Article

References (37)

1. Abrahamson GM, Rack K, Oscier DG, Fitchett M, Buckle VJ and Wainscoat JS. (1993). Am. J. Hematol., 42, 171-176.
2. Atkin NB and Baker MC. (1993). Cancer Genetics & Cytogenetics, 61, 123-125.
3. Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD and Campbell IG. (1996). Cancer Res., 56, 719-721.
4. Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela BH, Godorov G and Dubeau L. (1996). J. Nat. Cancer Inst., 88, 510-518.
5. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G and Jenkins RB. (1993). Cancer Res., 53, 2393-2398.
6. Davis M, Hitchcock A, Foulkes WD and Campbell IG. (1996). Cancer Res., 56, 741-744.
7. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Podratz KC and Jenkins RB. (1993). Cancer Res., 53, 4456-4460.
8. Eccles DM, Gruber L, Stewart M, Steel CM and Leonard RC. (1992a). Disease Markers, 10, 95-99.
9. Eccles DM, Russell SE, Haites NE, Atkinson R, Bell DW, Gruber L, Kelly K, Kitchener H, Leonard R and et al. (1992b). Oncogene, 7, 2069-2072.
10. Foulkes WD, Black DM, Stamp GW, Solomon E and Trowsdale J. (1993a). Int. J. Cancer, 54, 220-225.
11. Foulkes WD, Ragoussis J, Stamp GW, Allan GJ and Trowsdale J. (1993b). Br. J. Cancer, 67, 551-559.
12. Gallion HH, Powell DE, Smith LW, Morrow JK, Martin AW and van Nagell JR. (1990). Gynecologic Oncol., 38, 473-477.
13. Gallion HH, Powell DE, Morrow JK, Pieretti M, Case E, Turker MS, Hunter JE and van Nagell JR. (1992). Gynecologic Oncol., 47, 137-142.
14. Kerr J, Leary JA, Hurst T, Shih Y-C, Antalis TM, Friedlander M, Crawford E, Khoo SK, Ward B and Chenevix-Trench G. (1996). Oncogene, 13, 1815-1818.
15. Kunz J, Scherer SW, Klawitz I, Soder S, Du YZ, Speich N, Kalff-Suske M, Heng HH, Tsui LC and Grzeschik KH. (1994). Genomics, 22, 439-448.
16. Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT and Blick M. (1990). Cancer Res., 50, 2724-2728.
17. Lin JC, Scherer SW, Tougas L, Traverso G, Tsui LC, Andrulis IL, Jothy S and Park M. (1996). Oncogene, 13, 2001-2008.
18. Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M and Oishi M. (1993). Mol. Cell. Biol., 13, 6036-6043.
19. Parker SL, Tong T, Bolden S and Wingo PA. (1996). Cancer J. Clin., 46, 5-27.
20. Pieretti M, Powell DE, Gallion HH, Case EA, Conway PS and Turker MS. (1995). Human Pathol., 26, 393-397.
21. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS and Mok SC. (1995a). Oncogene, 11, 1249-1254.
22. Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS and Mok SC. (1995b). Cancer Res., 55, 2169-2172.
23. Sato T, Saito H, Morita R, Koi S, Lee JH and Nakamura Y. (1991). Cancer Res., 51, 5118-5122.
24. Scherer SW, Tompkins BJ and Tsui LC. (1992). Mammalian Genome, 3, 179-181.
25. Takahashi S, Shan AL, Ritland SR, DeLacey KA, Bostwick DG, Lieber MM and Jenkins RB. (1995). Cancer Res., 55, 4114-4119.
26. Tanaka K, Boice CR and Testa JR. (1989). Cancer Genet. Cytogenet., 43, 1-14.
27. Tangir J, Muto MG, Berkowitz RS, Welch WR, Bell DA and Mok SC. (1996). Oncogene, 12, 735-740.
28. Weitzel JN, Patel J, Smith DM, Goodman A, Safaii H and Ball HG. (1994). Gynecol. Oncol., 55, 245-252.
29. Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS and Mok SC. (1994). J. Nat. Cancer Inst., 86, 1549-1551.
30. Yang-Feng TL, Li S, Han H and Schwartz PE. (1992). Internat. J. Cancer, 52, 575-580.
31. Yang-Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers JT and Schwartz PE. (1993). Internat. J. Cancer, 54, 546-551.
32. Zenklusen JC, Bieche I, Lidereau R and Conti CJ. (1994a). Proc. Nat. Acad. Sci. USA, 91, 12155-12158.
33. Zenklusen JC, Oshimura M, Barrett JC and Conti CJ. (1994b). Oncogene, 9, 2817-2825.
34. Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ. (1994c). Cancer Res., 54, 6370-6373.
35. Zenklusen JC, Thompson JC, Klein-Szanto AJ and Conti CJ. (1995a). Cancer Res., 55, 1347-1350.
36. Zenklusen JC, Weitzel JN, Ball HG and Conti CJ. (1995b). Oncogene, 11, 359-363.
37. Zenklusen JC and Conti CJ. (1996). Mol. Carcinogen., 15, 167-175.